No Human Adverse-Event Programme Without a controlled clinical development programme, the frequency and severity of possible adverse reactions cannot be estimated reliably
Zowel in vitro als in vivo onderzoek met rattenpezen heeft aangetoond dat BPC-157 de collateralisatie bevordert en de dichtheid van fibroblasten verhoogt in het geval van blessures aan pezen, ligamenten en botten
Common (typically mild and transient): Increased appetite (moderate, less than GHRP-6) Flushing and warmth at the injection site or face Transient drowsiness or sleepiness, particularly with evening doses Mild water retention and peripheral edema Increased gastrointestinal motility Less Common: Elevations in cortisol and ACTH (moderate, comparable to hCRH) Mild prolactin elevation (less than TRH-induced levels) Numbness or tingling in extremities Joint stiffness Lightheadedness post-injection Rare or Theoretical Concerns: Impaired glucose metabolism and elevated blood glucose with prolonged use Potential tachyphylaxis (reduced response) with continuous daily dosing Theoretical promotion of existing malignancies through elevated GH/IGF-1 (applies to all GH-elevating compounds) Side effect incidence tends to be lower than with exogenous hGH because GHRP-2 stimulates endogenous GH synthesis within physiological regulatory limits
However, it is not safe for everyone
As it dissolves, a lot of it will be swallowed, but some will be absorbed directly by the tissues inside your mouth and transferred more directly to your bloodstream
They help improve productivity by decreasing accidents, downtime, absenteeism, theft and turnover
